Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982577priorityCriticalpatent/ECSP982577A/en
Publication of ECSP982577ApublicationCriticalpatent/ECSP982577A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos de fórmula (I): (gráfico), en la que X1, A, Ar1 X, y R son como se define en la memoria descriptiva, y sus sales farmacéuticamente aceptable, son nuevos, y son útiles como inhibidores de taquicina que actúan en los receptores NK2 y NK3 o una combinación de dos o mas de ellos.Compounds of formula (I): (graph), wherein X1, A, Ar1 X, and R are as defined in the specification, and their pharmaceutically acceptable salts, are new, and are useful as acting tachykinin inhibitors at NK2 and NK3 receptors or a combination of two or more of them.